Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Liverpool Featured PhD Programmes
University College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
Coventry University Featured PhD Programmes
University College London Featured PhD Programmes
"cancer" AND "drugs"×
10 miles

cancer drugs PhD Projects, Programs & Scholarships

We have 67 cancer drugs PhD Projects, Programs & Scholarships

  • "cancer" AND "drugs" ×
  • clear all
Order by 
Showing 1 to 10 of 67
  Cardiotoxicity of cancer drugs targeting the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade
  Prof A Clerk
Applications accepted all year round
"Heart failure is a leading cause of morbidity and mortality worldwide. The contractile cells of the heart, cardiomyocytes, possess many protective mechanisms, allowing them to withstand pathophysiological stresses.
  Exploration of novel approaches to anti-cancer treatment: manipulation of mutant p53
  Prof Y. Haupt, Dr S. Haupt
Applications accepted all year round
P53 is the most mutated gene in human cancer, affecting about half the cases of human cancer. We have recently identified novel regulators of mutant p53 using sophisticated loss of function whole genome high through put screen (image 1).
  Vitamin C microbubbles as therapeutic agents for colorectal cancer
  Prof SD Evans
Application Deadline: 7 January 2019
Recent published studies have shown that Vitamin C can target and kill colorectal cancer cells that contain gene mutations that are present in approximately 50% of colorectal cancer tumours.
  Magnetic hyperthemia for cancer treatment: synthesis, biofunctionalisation of nanoparticles for thermo-chemotherapy
  Prof N T K Thanh
Applications accepted all year round
Funded 3.5 years PhD. Open to UK nationals. Functional magnetic nanoparticles for cancer treatment. Supervisor. Prof Nguyen TK Thanh.
  MRC Precision Medicine DTP: Assessing the value of high-priced novel treatments in oncology in an era of precision medicine: methodological and policy tools
  Research Group: Institute of Health and Wellbeing
  Prof A Briggs, Dr K Boyd
Application Deadline: 7 January 2019
Supervisors. Prof Andrew Briggs. Dr Kathleen Boyd. Dr Peter Bach. PhD project summary. Health systems around the world are struggling to accommodate the increasing cost of new cancer treatments.
  Chemical modulation of cellular redox balance for cancer treatment
  Dr I Romero-Canelon
Applications accepted all year round
Platinum complexes, cisplatin, oxaliplatin and carboplatin, are the most widely used anticancer drugs. However, these DNA-targeting treatments are a low selectivity approach with deleterious consequences and a high incidence of resistance.
  Understanding and targetting telomere maintenance in cancer
  Dr D Clynes, Dr A Blackford, Dr R Gibbons
Application Deadline: 11 January 2019
Cancer occurs through the uncontrolled growth and division of cells, which eventually leads to the development of a tumour. The number of times a cell can divide is limited by the length of specialised DNA sequences found at the end of chromosomes.
  DNA Damage and Disease: Studying the signalling mechanisms cells use to respond to DNA damage and why defects in these pathways cause human diseases such as cancer.
  Dr A Blackford, Dr D Clynes
Application Deadline: 11 January 2019
Studying the signalling mechanisms cells use to respond to DNA damage and why defects in these pathways cause human diseases such as cancer.
  Bioactivity of 3D sugar-based heparan sulfate clusters for treating cancer
  Prof J Miller, Dr O Zubkova
Applications accepted all year round
A key factor in metastasis (the migration of cancer cells to remote parts of the body) is an enzyme called heparanase. It releases compounds from the extracellular matrix that encourage tumour growth.
  Synthesis and bioassays of 3D sugar-based clusters for treating cancer
  Dr O Zubkova
Applications accepted all year round
A key factor in metastasis (the migration of cancer cells to remote parts of the body) is an enzyme called heparanase. It releases chemicals from the extracellular matrix that encourage tumour growth.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.